[1] | Serafini, M., DelRio, D., Yao, D.N., Bettuzzi, S., and Peluso, I., “Health benefits of tea”, in Herbal Medicine: Biomolecular and Clinical Aspects, 2nd Edn, Chapter 12, eds Benzie, I.F.F., and Wachtel-Galor, S., 2011. |
|
[2] | Reygaert, W.C., “The antimicrobial possibilities of green tea,” Front Microbiol, 5. 434. Aug.2014. |
|
[3] | Ferruzzi, M.G., “The influence of beverage composition on delivery of phenolic compounds from coffee and tea,” Physiol Behav, 100 (1). 33-41. Apr.2010. |
|
[4] | Williamson, G., Dionisi, F., and Renouf, M., “Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages,” Mol Nutr Food Res, 55(6). 864-873. Jun.2011. |
|
[5] | Matsui, Y., Kobayashi, K., Masuda, H., Kigoshi, H., Akao, M., Sakurai, H., and Kumagai, H., “Quantitative analysis of saponins in a tea-leaf extract and their antihypercholesterolemic activity,” Biosci Biotechnol Biochem, 73(7). 1513-1519. Jul.2009. |
|
[6] | Katiyar, S.K., Afaq, F., Perez, A., and Mukhtar, H., “Green tea polyphenol (−)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress,” Carcinogenesis, 22(2). 287-294. Feb.2001. |
|
[7] | Jigisha, A., Nishant, R., Navin, K., and Pankaj, G., “Green tea: a magical herb with miraculous outcomes,” Int Res J Pharm, 3. 139-148. 2012. |
|
[8] | Subramani, C., and Natesh, R.K., “Molecular mechanisms and biological implications of green tea polyphenol, (-)-epigallo catechin-3-gallate,” Int J Pharm Biosci Tech, 1. 54-63. 2013. |
|
[9] | Folkman, J., “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nat Med, 1(1). 27-31. Jan.1995. |
|
[10] | Carmeliet, P., and Jain, R.K., “Angiogenesis in cancer and other diseases,” Nature, 407(6801).249-257. Sep.2000. |
|
[11] | Bergers, G., and Benjamin, L.E., “Tumorigenesis and the angiogenic switch,” Nat Rev Cancer, 3(6).401-410. Jun.2003. |
|
[12] | Folkman, J., “Role of angiogenesis in tumor growth and metastasis,” Semin Oncol, 29 (6 Suppl 16).15-18. Dec.2002. |
|
[13] | Zhang, S., Cao, Z., Tian, H., Shen, G., Ma, Y., Xie, H., Liu, Y., Zhao, C., Deng, S., Yang, Y., Zheng, R., Li, W., Zhang, N., Liu, S., Wang, W., Dai, L., Shi, S., Cheng, L., Pan, Y., Feng, S., Zhao, X., Deng, H., Yang, S., and Wei, Y., “SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo,” Clin Cancer Res, 17(13). 4439-4450. Jul.2011. |
|
[14] | Jaffe, E.A., Nachman, R.L., Becker, C.G., and Minick, C.R., “Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria,” J Clin Invest, 52(11). 2745-2756. Nov.1973. |
|
[15] | Pang, X., Yi, Z., Zhang, X., Sung, B., Qu, W., Lian, X., Aggarwal, B.B., and Liu, M., “Acetyl-11-ketob-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis,” Cancer Res, 69(14). 5893-5900. Jul.2009. |
|
[16] | Polverini, P.J., “The pathophysiology of angiogenesis,” Crit Rev Oral Biol Med, 6(3). 230-247.1995. |
|
[17] | Bischoff, J., “Cell adhesion and angiogenesis,” J Clin Invest, 99(3). 373-376. Feb.1997. |
|
[18] | Kaufmann, W.K, and Kaufman, D.G., “Cell cycle control, DNA repair and initiation of carcinogenesis,” FASEB J, 7(12). 1188-1189. Sep.1993. |
|
[19] | Kitanaka, C., and Kuchino, Y., “Caspase-independent programmed cell death with necrotic morphology,” Cell Death Differ, 6(6). 508-515. Jun.1999. |
|
[20] | Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S., “The role of autophagy in cancer development and response to therapy,” Nat Rev Cancer, 5(9). 726-734. Sep.2005. |
|
[21] | Lum, J.J., DeBerardinis, R.J., and Thompson, C.B., “Autophagy in metazoans: cell survival in the land of plenty,” Nat Rev Mol Cell Biol, 6(6). 439-448. Jun.2005. |
|
[22] | Siddiqui, I.A., Asim, M., Hafeez, B.B., Adhami, V.M., Tarapore, R.S., and Mukhtar, H., “Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer,” FASEB J, 25(4). 1198-1207. Apr. 2011. |
|
[23] | Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., and Corti, A., “Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study,” Cancer Res, 66(2).1234-1240. Jan.2006. |
|
[24] | Sagesaka, Y.M., Uemura, T., Watanabe, N., Sakata, K., and Uzawa, J., “A new glucuronide saponin from tea leaves (Camellia sinensis var. sinensis),” Biosci Biotechnol Biochem, 58(11). 2036-2040. Nov.1994. |
|
[25] | Murakami, T., Nakamura, J., Kageura, T., Matsuda, H., and Yoshikawa, M., “Bioactive saponins and glycosides. XVII. Inhibitory effect on gastric emptying and accelerating effect on gastrointestinal transit of tea saponins: structures of assamsaponins F, G, H, I, and J from the seeds and leaves of the tea plant,” Chem Pharm Bull, 48(11).1720-1725. Nov.2000. |
|
[26] | Kobayashi, K., Teruya, T., Suenaga, K., Matsui, Y., Masuda, H., and Kigoshi, H., “Isotheasaponins B1-B3 from Camellia sinensis var. sinensis tea leaves,” Phytochemistry, 67(13). 1385-1389. Jul.2006. |
|
[27] | Morikawa, T., Nakamura, S., Kato, Y., Muraoka, O., Matsuda, H., and Yoshikawa, M., “Bioactive Saponins and Glycosides. XXVIII. New Triterpene Saponins, Foliatheasaponins I, II, III, IV, and V, from Tencha (the Leaves of Camellia sinensis),” Chem Pharm Bull, 55(2). 293-298. Feb.2007. |
|
[28] | Sagesaka, Y.M., Uemura, T., Suzuki, Y., Sugiura, T., Yoshida, M., Yamaguchi, K., and Kyuki, K., “Antimicrobial and anti-inflammatory actions of tea-leaf saponin,”Yakugaku Zasshi (in Japanese), 116(3). 238-243. Mar.1996. |
|
[29] | Akagi, M., Fukuishi, N., Kan, T., Sagesaka, Y.M., and Akagi, R., “Anti-allergic effect of tea-leaf saponin (TLS) from tea leaves (Camellia sinensis var. sinensis),” Biol Pharm Bull, 20(5), 565-567. May.1997. |
|
[30] | Matsui, Y., Kobayashi, K., Masuda, H., Kigoshi, H., Akao, M., Sakurai, H., and Kumagai, H., “Quantitative analysis of saponins in a tea-leaf extract and their antihypercholesterolemic activity,” Biosci Biotechnol Biochem, 73(7). 1513-1519. Jul.2009. |
|
[31] | Xia, Y., Song, X., Li, D., Ye, T., Xu, Y., Lin, H., Meng, N., Li, G., Deng, S., Zhang, S., Liu, L., Zhu, Y., Zeng, J., Lei, Q., Pan, Y., Wei, Y., Zhao, Y., and Yu, L., “YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models,” Sci Rep, 4. 6031. Aug.2014. |
|
[32] | Muslim, N.S., Nassar, Z.D., Aisha, A.F., Shafaei, A., Idris, N., Majid, A.M., and Ismail, Z., “Antiangiogenesis and antioxidant activity of ethanol extracts of Pithecellobium jiringa,” BMC Complement Altern Med, 12. 210. Nov.2012. |
|
[33] | Okawara, M., Tokudome, Y., Todo, H., Sugibayashi, K., and Hashimoto, F., “Effect of β-cyclodextrin derivatives on the diosgenin absorption in Caco-2 cell monolayer and rats,” Biol Pharm Bull, 37(1).54-59. 2014. |
|
[34] | Okawara, M., Tokudome, Y., Todo, H., Sugibayashi, K., and Hashimoto, F., “Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration,” Biol Pharm Bull, 36(1). 36-40. 2013. |
|
[35] | Liu, M.J., Wang, Z., Ju, Y., Wong, R.N., and Wu, Q.Y., “DiosTA induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis,” Cancer Chemother Pharmacol, 55(1). 79-90. Jan.2005. |
|
[36] | Raju, J., Patlolla, J.M., Swamy, M.V., and Rao, C.V., “Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells,” Cancer Epidemiol Biomarkers Prev, 13(8).1392-1398. Aug.2004. |
|
[37] | Leger, D.Y., Liagre, B., Cardot, P.J., Beneytout, J.L., and Battu, S., “DiosTA dosedependent apoptosis and differentiation induction in human erythroleukemia cell line and sedimentation field-flow fractionation monitoring,” Anal Biochem, 335(2). 267-278. Dec.2004. |
|
[38] | Yang, Z., and Klionsky, D.J., “An overview of the molecular mechanism of autophagy,” Curr Top Microbiol Immunol, 335.1-32. 2009. |
|
[39] | Mizushima, N., “Autophagy: process and function,” Genes Dev, 21(22). 2861-2873. Nov.2007. |
|
[40] | Tong, Q., Zhao, Q., Qing, Y., Hu, X., Jiang, L., Wu, X., “Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells,” Steroids, 96C. 30-36. Dec.2014. |
|
[41] | Kim, J.D., Chaudhary, N., Seo, H.J., Kim, M.Y., Shin, T.S, “Theasaponin E₁ as an effective ingredient for anti-angiogenesis and anti-obesity effects,” Biosci Biotechnol Biochem, 78(2). 279-287. 2014. |
|